Search Within

Shyamprasad Deraje Vasudeva

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (6)
  2. Department of Pathology and Laboratory Medicine (6)
  3. GSK Faculty (6)
  4. Head and Neck Service (5)
  5. Solid Tumor Oncology Division (5)
  6. Biostatistics Service (4)

More Groups

People
  1. Alan Ho (3)
  2. Cristina Antonescu (3)
  3. Ian Ganly (3)
  4. James Fagin (3)
  5. Luc Morris (3)
  6. Ronald Ghossein (3)

More People

Years
  1. 2018 (2)
  2. 2017 (1)
  3. 2015 (1)
  4. 2013 (1)
  5. 2012 (1)
Publications
  1. Cancer Research (2)
  2. Cancer Cell (1)
  3. Clinical Cancer Research (1)
  4. Journal of Clinical Oncology (1)
  5. Lancet Oncology (1)
Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (1)
  3. Cell Press (1)
  4. Elsevier Science, Inc. (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated genomic analysis of Hurthle cell carcinoma reveals TMEM233/PRKAB1 fusion as a novel oncogenic driver
    Meeting Abstract

    Dong, Y.; Ganly, I.; Makarov, V.; Kuo, F.; Deraje, S.; Reznik, E.; Seshan, V.; Nanjangud, G.; Morris, L.; Riaz, N.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Integrated genomic analysis of Hürthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes
    Journal Article

    Ganly, I.; Makarov, V.; Deraje, S.; Dong, Y.; Reznik, E.; Seshan, V.; Nanjangud, G.; Eng, S.; Bose, P.; Kuo, F.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Genomic alterations in fatal forms of non-anaplastic thyroid cancer: Identification of MED12 and RBM10 as novel thyroid cancer genes associated with tumor virulence
    Journal Article

    Ibrahimpasic, T.; Xu, B.; Landa, I.; Dogan, S.; Middha, S.; Seshan, V.; Deraje, S.; Carlson, D. L.; Migliacci, J.; Knauf, J. A.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Alliance A091104: A phase II trial of MK-2206 in patients (pts) with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Ho, A. L.; Foster, N. R.; Meyers, J. P.; Vasudeva, S. D.; Katabi, N.; Antonescu, C. R.; Pfister, D. G.; Horvath, L. E.; Erlichman, C.; Schwartz, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial
    Journal Article

    Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S. M.; Reed, D. R.; Okuno, S. H.; more...
    Lancet Oncology (2013)

    Fulltext@MSK | Save
  • PDGF receptor alpha is an alternative mediator of rapamycin-induced akt activation: Implications for combination targeted therapy of synovial sarcoma
    Journal Article

    Ho, A. L.; Vasudeva, S. D.; Lae, M.; Saito, T.; Barbashina, V.; Antonescu, C. R.; Ladanyi, M.; Schwartz, G. K.
    Cancer Research (2012)

    Fulltext@MSK | Save